Cidara Therapeutics, Inc. (NASDAQ:CDTX) Given Average Recommendation of “Buy” by Brokerages
Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) have been assigned a consensus recommendation of “Buy” from the nine brokerages that are presently covering the firm, MarketBeat reports. Seven research analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average 1 […]
Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) have been assigned a consensus recommendation of “Buy” from the nine brokerages that are presently covering the firm, MarketBeat reports. Seven research analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average 1 […]
